Preview

Bulletin Physiology and Pathology of Respiration

Advanced search

PLACENTAL GROWTH FACTOR AS A MARKER OF THE THREATENED EARLY MISCARRIAGE IN WOMEN WITH CYTOMEGALOVIRUS INFECTION

https://doi.org/10.12737/article_59360cc93f6447.76641762

Abstract

The aim of study was to establish the dependence of the threatened early miscarriage on the level of placental growth factor (PlGF) in the blood of pregnant women with different activity of cytomegalovirus (CMV) infection. There was conducted a prospective study by case-control type of 100 women at 9-11 weeks of gestation, among whom 83 were CMV-seropositive and 17 were CMV-seronegative. Further categorization into subgroups was performed taking into account the markers of CMV replication activity and the nature of pregnancy complications. Markers of highly active CMV infection and a significant decrease of PlGF in the blood (p<0.001) of CMV-seropositive women whose pregnancy ended with spontaneous abortion at 10-11 weeks of gestation were revealed in 15.7% of cases. In 53% of cases, pregnancy was complicated by the threatened miscarriage, but with subsequent prolongation. In this subgroup with less expressed activity of CMV, PlGF values were higher (p<0.01). In 31.3% of cases, the latent course of the disease was diagnosed, where the level of the enzyme did not significantly differ from those in the control group, which correlated with the minimal risk of development of the threatened miscarriage. Morphological study of the villous chorion from CMV-seropositive women with spontaneous miscarriage revealed cytomegalic cells in the trophoblast, multiple avascular and necrotic villi. The obtained data shows the CMV dependent inhibition of secretion of the PlGF by trophoblast cells, which is determined by the level of viral activity and leads to the violation of placental morphology and reduction of placental blood flow, intrauterine growth restriction and at the high viral load - to fetal death induced by it.

About the Authors

I. A. Andrievskaya
Far Eastern Scientific Center of Physiology and Pathology of Respiration
Russian Federation


M. T. Lutsenko
Far Eastern Scientific Center of Physiology and Pathology of Respiration
Russian Federation


K. K. Petrova
Far Eastern Scientific Center of Physiology and Pathology of Respiration
Russian Federation


E. Yu. Kochegarova
Far Eastern Scientific Center of Physiology and Pathology of Respiration
Russian Federation


N. G. Prikhodko
Amur Regional Children's Clinical Hospita
Russian Federation


References

1. Кулаков В.И., Гуртовой Б.Л., Орджоникидзе Н.В., Тютюнник В.Л. Цитомегаловирусная инфекция в акушерстве. М: ГЭОЭТАР-Мед, 2001. 32 с.

2. Луценко М.Т., Андриевская И.А., Довжикова И.В. Морфофункциональная характеристика фетоплацентарного комплекса у беременных, перенесших обострение герпес-вирусной инфекции, и патоморфологические изменения в органах плода // Архив патологии. 2010. Т.72, №4. С.47-49.

3. Милованов А.П., Фокин Е.И., Рогова Е.В. Основные патогенетические механизмы хронической плацентарной недостаточности // Архив патологии. 1995. Т.57, № 4. С.11-16.

4. Радзинский В.Е., Запертова Е.Ю., Мисник В.В. Генетические и иммунологические аспекты привычного невынашивания беременности // Акушерство и гинекология. 2005. №6. С.24-29.

5. Сидельникова В.М. Привычная потеря беременности. М.: Триада-Х, 2005. 304 с.

6. Соколов Д.И. Васкулогенез и ангиогенез в развитии плаценты // Журнал акушерства и женских болезней. 2007. Т.LVI, №3. С.129-133.

7. Andrievskaya I.A., Lucenko M.T., Babenko O.P. Specific and non-specific factors of humoral immunity as markers for pregnancy loss in women with cytomegalovirus infection // International Journal of Biomedicine. 2015. Vol.5. №4. P.184-187. doi: 10.21103/Article5(4)_OA2

8. DiSalvo J., Bayne M.L., Conn G., Kwok P.W., Trivedi P.G., Soderman D.D., Palisi T.M., Sullivan K.A., Thomas K.A. Purification and characterization of a naturally occurring vascular endothelial growth factor-placenta growth factor heterodimer // J. Biol. Chem. 1995. Vol.270, №13. P.7717-7723.

9. Forbes K., Westwood M. Maternal growth factor regulation of placental development and fetal growth // J. Endocrinol. 2010. Vol.207, №1. P.1-16.

10. Kurz H., Wilting J., Sandau K., Christ B. Automated evaluation of angiogenic effects mediated by VEGF and PLGF homo-and heterodimers // Microvasc. Res. 1998. Vol.55, №1. P.92-102.

11. Khaliq A., Li X.F., Shams M., Sisi P., Acevedo C.A., Whittle M.J., Weich H., Ahmed A. Localization of placenta growth factor (PLGF) in human term placenta // Growth Factors. 1996. Vol.13, №3-4. P.243-250.

12. Plaisier M., Dennert I., Rost E., Koolwijk P., van Hinsbergh V.W., Helmerhorst F.M. Decidual vascularization and the expression of angiogenic growth factors and proteases in first trimester spontaneous abortions // Hum. Reprod. 2009. Vol.24, №1. P.185-197.

13. Shore V.N., Wang T.N., Wang T.L., Torry R.G., Caudle M.R., Torry D.S. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast // Placenta. 1997. Vol.18, №8. P.657-669.

14. Tjoa M.L., van Vugt J.M., Mulders M.A., Schutgens R.B., Oudejans C.B., van Wijk I.J. Plasma placenta growth factor levels in midtrimester pregnancies // Obstet. Gynecol. 2001. Vol.98, №4. Р.600-607.


Review

For citations:


Andrievskaya I.A., Lutsenko M.T., Petrova K.K., Kochegarova E.Yu., Prikhodko N.G. PLACENTAL GROWTH FACTOR AS A MARKER OF THE THREATENED EARLY MISCARRIAGE IN WOMEN WITH CYTOMEGALOVIRUS INFECTION. Bulletin Physiology and Pathology of Respiration. 2017;(64):55-59. (In Russ.) https://doi.org/10.12737/article_59360cc93f6447.76641762

Views: 543


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1998-5029 (Print)